Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conclusions: Considerations regarding SERMs.

B K Dunn1, M Anthony, S Sherman

  • 1Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20852, USA. dunnb@mail.nih.gov

Annals of the New York Academy of Sciences
|January 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profile of and risk factors for early unplanned readmissions in patients with acute necrotizing pancreatitis.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2023
Same author

Complexation reduces nickel toxicity to purple sea urchin embryos (Strongylocentrotus purpuratus), a test of biotic ligand principles in seawater.

Ecotoxicology and environmental safety·2021
Same author

Carcinoma esophagus and rat-tail sign.

QJM : monthly journal of the Association of Physicians·2020
Same author

Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.

The British journal of dermatology·2020
Same author

Constraining the Spin-Dependent WIMP-Nucleon Cross Sections with XENON1T.

Physical review letters·2019
Same author

First Results on the Scalar WIMP-Pion Coupling, Using the XENON1T Experiment.

Physical review letters·2019
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Selective estrogen receptor modulators (SERMs) show inconsistent efficacy and toxicity, questioning their use in disease prevention. Further research is needed to clarify their cellular activity and clinical application.

Area of Science:

  • Pharmacology and Toxicology
  • Oncology
  • Clinical Trial Design

Background:

  • Selective estrogen receptor modulators (SERMs) are under investigation for disease prevention and treatment.
  • Concerns exist regarding SERM carcinogenicity and efficacy, particularly when extrapolating from animal models to humans.
  • The precise molecular and cellular mechanisms of SERM action remain incompletely understood.

Purpose of the Study:

  • To address critical considerations and unresolved questions surrounding the clinical application of SERMs.
  • To evaluate the discrepancies between preclinical data and human outcomes for SERMs.
  • To discuss the challenges in SERM research, including semantic inconsistencies and optimal clinical trial design.

Main Methods:

  • Review and synthesis of existing research on SERM carcinogenicity, efficacy, and mechanisms of action.

Related Experiment Videos

  • Analysis of inconsistencies between animal and human data, and between epidemiological and randomized trial data.
  • Discussion of the role of "occult cancers" in SERM efficacy and the need for validated surrogate markers.

    • Main Results:

    • Inconsistencies in SERM efficacy and toxicity (carcinogenicity) between animal models and humans necessitate careful clinical evaluation.
    • The cellular mechanisms of SERMs are not fully elucidated, impacting the interpretation of their actions.
    • Discrepancies exist in understanding estrogen's role in cardiovascular disease and SERM effects.

    Conclusions:

    • The clinical utility of SERMs, especially in disease prevention for healthy individuals, requires further rigorous investigation due to inconsistent preclinical and clinical findings.
    • Standardization of semantics and robust clinical trial designs, such as large, simple randomized trials, are crucial for advancing SERM research and application.
    • Extrapolation of clinical trial results to practice necessitates careful consideration of statistical significance and clinical relevance.